CAS 692054-06-1

AZD0424

CAS : 692054-06-1

Formule : C₂₅H₂₉ClN₆O₅

Couleur et forme : Neat

Ref: TR-A988970

AZD0424

CAS : 692054-06-1

AZD0424 is a potent, selective and orally bioavailable HER2 inhibitor. It has been shown to inhibit the proliferation of human breast cancer cells in vitro and in vivo. AZD0424 is currently being investigated for the treatment of HER2+ metastatic breast cancer, with promising results in early clinical trials. It also inhibits tumor growth and metastasis in colorectal cancer patients who have received chemotherapy but are resistant to cisplatin treatment. AZD0424 has been shown to have an anti-tumor effect on solid tumour cells, inhibiting cellular transformation and tumor growth by blocking epidermal growth factor receptor activation.

Formule : C₂₅H₂₉ClN₆O₅

Degré de pureté : Min. 95%

Masse moléculaire : 529 g/mol

Ref: 3D-SCB05406

AZD0424

CAS : 692054-06-1

AZD0424: oral Src/Abl kinase inhibitor; potential anticancer; induces apoptosis, cell cycle arrest in lymphoma.

Formule : C₂₅H₂₉ClN₆O₅

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 528.99

Ref: TM-T14370